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Abstract
Daptomycin and A54145 are homologous lipopeptide antibiotics that permeabilize the cell membranes
of  Gram-positive  bacteria.  Membrane  permeabilization  depends  on  the  presence  of  both
phosphatidylglycerol (PG) and calcium, and it involves the formation of oligomeric transmembrane
pores that consist of approximately 6-8 subunits. We here show that each lipopeptide molecule binds
two calcium ions in separable, successive steps. The first calcium ion causes the lipopeptide molecule
to bind to  the target  membrane,  and likely to  form a loosely associated oligomer.  Higher  calcium
concentrations induce binding of a second ion, which produces the more tightly associated and more
deeply membrane-inserted final, functional form of the oligomer. Both calcium-dependent steps are
accompanied by fluorescence signals that indicate transition of specific amino acid residues into less
polar  environments,  suggestive of insertion into the target  membrane.  Our findings  agree with the
earlier observation that two of the four acidic amino acid residues in the daptomycin molecule are
essential for antibacterial activity. 
Introduction
Daptomycin  and  A54145  are  two  homologous  acidic  lipodepsipeptide  antibiotics  (Figure  1)  that
permeabilize the cell membranes of Gram-positive bacteria in a calcium-dependent manner. The only
molecule  in  the  target  membrane  proven  to  be  specifically  required  for  antibacterial  activity  is
phosphatidylglycerol, which is a major constituent of bacterial cell membranes [1]. The activity of both
antibiotics  coincides  with  the  formation  of  membrane-associated  oligomers  [2].  Mixtures  of
daptomycin  with  CB-182,462,  a  semisynthetic  A54145  derivative,  form hybrid  oligomers  that  are
partially functional, indicating that daptomycin and A54145 are functionally closely related [2]. 
All known steps in the activity of daptomycin and A54145 can be recapitulated in a simple liposome
model that contains only phosphatidylcholine (PC) and phosphatidylglycerol (PG). In this model, it can
be shown that calcium is required for membrane binding [3, 4], and that PG and calcium are required
for oligomerization  [5] and pore formation  [6]. While the requirement of calcium for activity is thus
well documented, the interaction is not clearly understood in molecular detail, and the stoichiometric
ratio  of  calcium  to  daptomycin  is  not  clear.  Circular  dichroism  (CD)  experiments  showed  that
daptomycin may undergo two calcium-dependent structural transitions. A first, minor transition can be
observed when calcium is added to daptomycin in solution; the second, major transition occurs in the
presence of calcium and membranes containing PG [4]. NMR studies of daptomycin in solution yielded
a stoichiometry of one calcium ion per lipopeptide molecule [7]. 
Using  isothermal  calorimetry  and  fluorescence  spectroscopy,  we  here  show  that  daptomycin  and
A54145,  when  mixed  with  PG-containing  membranes,  successively  bind  two  calcium  ions  per
lipopeptide molecule.  A singly bound state can be detected in which the lipopeptide molecules are
associated with the membrane, but in which their peptide moieties do not tightly interact with one
another, although aggregation of the acyl tails is evident from experiments reported in a separate study.
Binding  of  the  second  calcium ion  converts  these  loosely  connected  oligomers  to  a  more  tightly
associated and more deeply membrane-inserted state, presumably mediated by conformational changes
that ultimately also lead to transmembrane pore formation. 
Materials and Methods
Liposome  preparation. Large  unilamellar  vesicles  (LUV)  for  use  in  both  ITC  and  fluorescence
experiments  were  prepared  by  polycarbonate  membrane  extrusion  [8] from  equal  proportions  of
phosphatidylglycerol  (PG)  and  posphatidylcholine  (PC)  in  Hepes-buffered  saline  as  described
previously  [5]. In fluorescence experiments, dimyristoyl lipids (DMPG, DMPC) were used, whereas
dioleoyl lipids (DOPG, DOPC) were used  for ITC experiments. All lipids were obtained from Avanti
Polar Lipids, Alabaster, AL.  
Isothermal calorimetry (ITC). ITC titrations were carried out on a MicroCal ITC 200 instrument (GE
Healthcare). LUV (DOPG/DOPC) were loaded into the ITC cell at final concentrations of 3.55 to 4.55
mM total lipid, together with 150 to 490 μM of daptomycin; the concentration of the latter was adjusted
by spectrophotometry.  The single kynurenine residue of daptomycin absorbs at  360 nm; the molar
extinction coefficient was taken to be 4,500 [9]. The temperature was kept at 25ºC. 
Calcium chloride was loaded into the syringe at 5 or 10 mM and injected in increments of 1 or 2 μL.
Heat  peaks  were  baseline-corrected  and  integrated  using  the  Origin  software  supplied  with  the
instrument. The integrated heats were fitted using models that assumed a single type of binding sites, or
the  sequential  binding  to  two  types  of  sites,  with  either  fixed  or  variable  calcium/daptomycin
stoichiometry, as detailed in the Results section. 
Synthesis of acrylodan-labeled A54145 and daptomycin. Acrylodan is a polarity-sensitive fluorescent
dye whose emission undergoes a large blue shift and a pronounced increase in quantum yield upon
transition from aqueous solutions to apolar environments such as lipid bilayers  [10]. It reacts most
readily  with  thiol  groups  but  also  with  free  amino  groups  [11].  Acrylodan  (Setareh  Biotech,
Eugene/OR) was attached to the unique free side chain amino groups of lysine-8 in A54145 Factor D
and of ornithine-6 in daptomycin (both generously provided by Jared Silverman, Cubist Inc.). In the
case of A54145, acrylodan was reacted directly with the amino group (cf. Figure 1). 5 mg of A54145
was dissolved in 250 μL of sodium phosphate (50 mM, pH 8.0) and supplemented with acrylodan (1
mg, dissolved in 250 μL of DMF), and the reaction was incubated for 5 days at room temperature. 
With daptomycin,  the amino group of  ornithine-6 was first  converted  to  a  sulfhydryl  group using
Traut's reagent [12], to which acrylodan was then attached. To a solution of daptomycin (20 mg, 0.0123
mmol) in potassium phosphate buffer (50 mM, pH 8.0, 0.5 mL) was added Traut’s reagent (3.0 mg,
0.0281 mmol, 1.8 equiv). The mixture was stirred for 1 h. A solution of acrylodan (5.5 mg, 0.0246
mmol, 2 equiv) in DMF (1 mL) was added and the mixture stirred for 24 h. 
The products were purified by HPLC on a reversed-phase column (Higgins Analytical, C18 10 μm)
using a mobile phase of 0.1% aqueous trifluoroacetic acid with acetonitrile gradients from 40% to 50%
(for  the  A54145 adduct)  or  from 50% to  80% (for  the  daptomycin  adduct).  Product  purities  and
identities were confirmed by analytical HPLC and mass spectrometry. Concentrations were determined
using molar extinction coefficients at 365 nm of 16,400 M-1 cm-1 for the A54145 adduct and of 20,900
M-1 cm-1 for the daptomycin adduct (the higher coefficient in the latter case accounts for the kynurenine
residue  contained  in  daptomycin).  The  labeled  derivatives,  purified  to  homogeneity,  retained
approximately 50% (A54145) or 25% (daptomycin) of the antibacterial activities of their respective
parent compounds (data not shown). 
Fluorescence measurements. Fluorescence emission spectra as well as anisotropy measurements were
acquired using a  PTI QuantaMaster  4  instrument.  The samples  contained Hepes-buffered (pH 7.4)
NaCl (150 mM) with native and labeled daptomycin and A54145, alone or in combination at final total
concentrations  of  3  μM,  as  well  as  calcium at  various  concentrations,  as  indicated  in  the  Results
section. Excitation wavelengths were 280 nm for tryptophan in native A54145, 360 nm for acrylodan,
and 365 nm for kynurenine in native daptomycin. All fluorescence measurements were carried out at 37
°C. 
Results
Stoichiometry of calcium binding by ITC. The calcium-dependent membrane binding of daptomycin
can be observed by ITC  [2, 13]. We here used this method to determine the stoichiometric ratio of
calcium to lipopeptide. Calcium (5 or 10 mM) was titrated into a sample that contained between 150
and 510 μM of daptomycin and an excess of DOPC/DOPG liposomes. 
Figure 2 shows a single, representative ITC experiment fitted to various kinetic models. Panel A shows
the raw trace and the baseline generated by the Origin software. The data points in panels B and C are
the  peak  areas  integrated  relative  to  this  baseline.  An  initial  downward  slope  is  apparent  in  the
integrated data points but not in the height of the raw peaks; this discrepancy is most likely due to a
decrease in the reaction rate as daptomycin becomes saturated with calcium.
When a single class of binding sites is assumed that binds all calcium ions with the same affinity, a
stoichiometry of 2 fits the data better than 1 or 3, although none of the models fits particularly well
(panel B). If we allow the stoichiometry to vary freely, a model that assumes two sequential binding
sites with distinct affinities produces a better fit, and a more plausible stoichiometry (2.06 calcium ions
per daptomycin molecule), than a model that assumes a variable number of sites with uniform affinity
(2.40 calcium ions per daptomycin molecule). In six independent experiments, the sequential two-site
model produced a stoichiometry of 1.81±0.29. The most plausible integral value for the stoichiometry
therefore is 2. The enthalpies and dissociation constants also obtained using this model are reported in
Table 1. 
Calcium-dependent  changes  in  the  fluorescence  emission  of  native  daptomycin  and  acrylodan-
daptomycin. It has previously been reported that both native daptomycin  [3, 4] and daptomycin that
was labeled at its ornithine-6 residue with nitrobenzoxadiazole (NBD)  [5, 14] undergo fluorescence
increases when binding to phospholipid membranes in the presence of calcium. For this  study,  we
replaced NBD with acrylodan, another fluorescent label that exhibits greater sensitivity to changes in
environmental polarity [10]. (While acrylodan overlaps both the excitation and the emission spectra of
the  kynurenine  residue  natively  contained  in  daptomycin,  both  its  extinction  coefficient  and  its
quantum yield are significantly higher. Accordingly, acrylodan dominates the emission spectrum of the
labeled compound.)
We separately incubated native daptomycin (Figure 3A) and acrylodan-daptomycin (Figure 3B) with
PC/PG membranes and observed their changes in fluorescence as the concentration of calcium was
raised stepwise from 0 to 10 mM. The intrinsic fluorescence of kynurenine-13 in native daptomycin
shows little response up to 0.1 mM calcium but then rapidly increases, approaching saturation at 1 mM
(Figure 3A). In contrast,  the fluorescence of acrylodan attached to ornithine-6 rises up sooner and
already peaks at 0.1 mM calcium but then decreases again at higher concentrations (Figure 3B). The
different responses to increasing calcium concentrations are clearly evident in Figure 3D: acrylodan at
ornithine-6 responds first  and peaks when kynurenine just  starts  to react.  Acrylodan emission then
decreases progressively as kynurenine emission approaches its maximum. 
The most straightforward explanation for the decrease in acrylodan fluorescence at  higher calcium
concentrations consists in concentration-dependent self-quenching, which also occurs with the label
NBD attached to the same residue, and which is indicative of daptomycin oligomer formation [5]. In
keeping with this assumption, the extent of quenching is reduced when acrylodan-daptomycin is mixed
with an excess of unlabeled daptomycin before addition to the membranes (Figure 3C); within the
hybrid oligomers formed from the mixtures, the acrylodan molecules will mostly be separated from one
another. (The unlabeled species used in this experiment was the synthetic daptomycin variant E12W13,
in which the kynurenine residue has been replaced with tryptophan [15], and which therefore does not
contribute any fluorescence upon excitation at 360 nm.)
Concomitantly with calcium binding, the emission spectra of kynurenine and particularly of acrylodan
also  undergo  significant  blue  shifts.  The  observed  fluorescence  signals  of  both  kynurenine  and
acrylodan  are  compatible  with  their  transition  to  a  more  hydrophobic  environment,  which  likely
corresponds to the apolar interior of the target membrane.
Calcium-dependent  fluorescence changes in  native and acrylodan-labeled A54145. The lipopeptide
A54145 resembles daptomycin structurally and functionally, but unlike daptomycin does not contain
kynurenine, so that the intrinsic fluorescence of its  tryptophan residue is unmasked  [2]. Figure 4A
shows that the tryptophan residue undergoes an appreciable blue shift, again suggestive of insertion
into a hydrophobic environment, at calcium concentrations greater than 0.1 mM.
Figure  4B shows  the  response  of  A54145-acrylodan  to  incremental  addition  of  calcium.  As  with
acrylodan-daptomycin, calcium induces a pronounced blue-shift, and the emission intensity increases
rapidly up to 0.1 mM calcium but drops back when calcium is raised further. This drop is again due to
oligomer formation and self-quenching, since it can be suppressed by mixing the acrylodan derivative
with an excess of unlabeled A54145 prior to incubation with membranes (Figure 4C). 
Figure 4D compares the fluorescence signals of native and acrylodan-labeled A54145. We can observe
that the initial increase in acrylodan fluorescence precedes the tryptophan emission shift, which in turn
slightly precedes the drop in the acrylodan emission at higher calcium concentrations. The findings are
again compatible with the binding of calcium in two successive steps. Like ornithine-6 of daptomycin,
lysine-8 of A54145 inserts into the membrane when the first calcium ion binds, and it interacts with the
same residue in adjacent subunits when the second calcium ion binds. Similarly, like kynurenine-13 of
daptomycin,  tryptophan-1 of A54145 inserts  into the membrane concomitantly with binding of the
second calcium ion. 
Two  successive  steps  of  membrane  interaction  can  also  be  detected  by  fluorescence  anisotropy
measurements  (Figure  5).  The anisotropy of  tryptophan-1 in  A54145 rises  concomitantly with  the
emission blue shift (cf. Figure 4D), which is accounted for by the higher viscosity inside the membrane
than outside. In contrast, the anisotropy of kynurenine-13 in daptomycin rises more rapidly, reaching a
maximum already at 0.1 mM of calcium; that is, with this residue, the increase in anisotropy precedes
the spectral shift that signals membrane insertion. The early increase in anisotropy may be due to a low
mobility  of  this  residue  relative  to  the  body  of  the  peptide,  which  would  restrict  the  motion  of
kynurenine as soon as any part of the peptide becomes membrane-attached. The anisotropy declines
again as calcium is raised further. This may be caused by increasing homo-FRET concomitantly with
the aggregation of daptomycin into larger oligomers. Overall, therefore, the anisotropy experiments are
compatible with the interpretations proposed for the spectral changes.
Discussion
Figure 6 summarizes the experimental findings of this study. In this figure, the fluorophores contained
in labeled and in unlabeled daptomycin and A54145 are combined into a single schematic structure.
Binding of the first calcium ion enhances the fluorescence of the extrinsic labels attached to ornithine-6
in daptomycin and to lysine-8 in A54145. Binding of the second calcium ion elicits signals from the
intrinsically  fluorescent  residues  tryptophan-1  and  kynurenine-13.  Concomitantly,  the  fluorescence
signals  of the labeled residues 6 and 8 undergo self-quenching due to  mutual  interaction.  All  four
fluorophores transition to a more hydrophobic environment upon calcium binding. Thus, residues 1, 6,
8, and 13 likely all participate in the membrane interaction of daptomycin/A54145, and residues 6 and
8 additionally participate in the mutual interaction of subunits within the membrane-bound oligomer.
Whether or not this mutual interaction involves subunits located in opposite membrane leaflets (as
suggested by the cartoon) remains to be determined. 
The figure  also includes  the key findings  of  another  recent  study,  in  which pyrene moieties  were
semisynthetically incorporated into the fatty acyl tail  of A54145  [16]. As in the current study, two
successive  calcium-dependent  transitions  were observed,  which occurred  at  calcium concentrations
very similar to those reported here. In contrast to the present study, however, a mutual interaction of the
labeled molecules, in the form of pyrene excimer fluorescence, was observed already after the first
calcium-dependent  transition.  The  excimer  intensity  increased  further  in  the  second  transition,
indicating that the interaction between labeled acyl residues became tighter and/or involved a larger
number of subunits. 
Collectively, the findings from both studies can be interpreted as follows: Binding of the first calcium
ion causes monomeric lipopeptide molecules to bind to the membrane and to form a loosely associated
structure, in which the acyl tails interact, but the peptide moieties – or at least, residues 6 and 8 – do
not.  This  initial  aggregate  transitions  to  the  final,  tightly  associated  and  functional  oligomer
concomitantly  with  binding  of  the  second  calcium  ion.  This  mechanism  is  reminiscent  of  many
structurally  diverse  oligomer-forming,  membrane-permeabilizing  protein  toxins  that  also  form
oligomeric “pre-pores” prior to the functional, membrane-inserted pores [17-19]. 
The observations from fluorescence correlate well with the findings from ITC experiments. With all
binding models tested, the whole-number stoichiometric ratio of calcium to daptomycin that best fit the
experimental data was 2. The assumption of successive binding to sites with different affinities leads to
a notably improved fit relative to the simpler model that assumes a single class of binding sites. If we
accept that each lipopeptide molecule binds two calcium ions, the question arises which amino acid
residues are involved in this interaction. Prime candidates are the four anionic residues, three of which
occur in conserved positions (cf. Figure 1). Using substitutions with uncharged amino acid residues, it
has  previously  been  shown  that  both  aspartate-7  and  aspartate-9  in  daptomycin  are  essential  for
antibacterial activity, while replacement of the other two residues reduced, but did not abrogate activity
[20,  21].  It  is  noteworthy also  that  anionic  residues  in  positions  7  and  9  are  conserved  between
daptomycin/A45145 and the amphomycin/friulimicin family [22], which is also calcium-dependent but
exhibits  a  different  mode  of  antibacterial  action  [23].  On  the  other  hand,  a  recently  synthesized
daptomycin  derivative,  in  which  kynurenine-13  was  replaced  with  tyrosine,  showed  signs  of
significantly diminished calcium affinity  [15], suggesting that one calcium binding site may involve
methyl-glutamate-12, which is located next to residue 13. In any case, the two calcium binding sites
remain to be unambiguously determined by future experimental studies. 
A possible objection to the fluorescence experiments presented here is that the labelled derivatives
displayed reduced antibacterial activity, which might be due to their impeded interaction with calcium
and/or membrane lipids. While this possibility cannot be excluded, it should be noted that the labeled
derivatives detected the first calcium-dependent transition, whereas the two native compounds detected
the second transition. If indeed the two labelled compounds had reduced calcium affinity, this would
imply that the first transition should precede the second one by a larger calcium concentration interval
than suggested by the results presented here. It seems unlikely, however, that the distinction between
both transitions as such arises solely as an artifact of the fluorescent labeling. In this context, it is also
worth noting that two successive transitions were also evident in a related study that used only a single
labeled  derivative  [16].  Moreover,  with  native  daptomycin,  the  anisotropy of  kynurenine-13  rises
before the residue inserts into the lipid bilayer (cf. Figures 3A and 5, respectively). This observation,
which  does  not  involve  any  extrinsic  label, also  suggests  two  successive  stages  of  membrane
interaction.
In summary,  our study combines ITC and fluorescence methods to  determine the stoichiometry of
calcium binding to daptomycin and A54145, and to clarify the relationship between calcium binding,
membrane binding, and oligomer formation. The exact binding sites of the two calcium ions that bind
to each lipopeptide molecule remain to be elucidated in future experiments. 
Table 1: Thermodynamic parameters for calcium binding
Stoichiometries, reaction heats (ΔH), and association constants (K) for calcium binding to daptomycin
in the presence of an excess of DOPC/DOPG vesicles. Parameters are reported only for the successive
two-site model (cf. Figure 2). Averages and standard deviations were obtained from 6 independent
experiments. 
Parameter Average Standard deviation
Stoichiometry (calcium/lipopeptide) 1.81 0.29
First step ΔH -4.36 kJ/mol 0.48 kJ/mol
K 5.65 × 104 M-1 3.65 × 104 M-1
Second step ΔH -6.57 kJ/mol 1.14 kJ/mol
K 2.98 × 104 M-1 1.61 × 104 M-1
Figure legends
Figure 1: Structures of daptomycin and of A54145 Factor D. “R” represents the fatty acyl tail that is
decanoic  acid  in  daptomycin  but  variable  in  A54145.  Residues  that  confer  intrinsic  fluorescence
(kynurenine-13 in daptomycin and tryptophan-1 in A54145) as well as those derivatized with acrylodan
(ornithine-6  in  daptomycin  and  lysine-8  in  A54145)  are  highlighted  in  blue;  acidic  residues  are
highlighted in red. 
Figure 2: A representative isothermal calorimetry trace of calcium binding to daptomycin (510 μM) and
LUV composed of DOPC and DOPG (1:1; final concentration of DOPG 3.55 mM). Calcium (10 mM)
was injected in increments of 1 μL into a cell volume of 200 μL. A: raw thermal trace (black). The ΔH
values in B and C represent the peak areas integrated relative to the baseline (red). The lipid control
contained  the  same amount  of  lipids  but  no  daptomycin;  the  experiment  was  terminated  after  70
minutes. B: The ΔH values were fitted with a model that assumes as single set of binding sites, with
stoichiometric ratios (n) of 1, 2, or 3 calcium ions per daptomycin molecule. C: The ΔH values were
fitted with a model that assumes a variable number (n) of calcium ions binding to a single type of sites
or to two successive sites, respectively. 
Figure 3: Fluorescence response of native daptomycin (A,C) and of acrylodan-daptomcyin (B,C) to
increasing amounts of calcium. A: Native daptomycin (3 μM) was added to DMPC/DMPG LUV (250
μM total lipid). Calcium was added at the indicated concentrations, and the fluorescence of kynurenine-
13 was excited at 365 nm. B: The same experiment was performed with acrylodan-daptomycin (3 μM).
C: Acrylodan-daptomycin (0.5 μM) was mixed with a 5-fold molar excess of the synthetic daptomycin
analogue E12W13 [14] prior to addition to membranes. Acrylodan fluorescence was excited at 360 nm.
D: Maxima of acrylodan and kynurenine fluorescence emission at increasing calcium concentrations.
The initial rise in acrylodan fluorescence subsides and partially reverses concomitantly with the rise in
kynurenine fluorescence. 
Figure 4: Fluorescence response of native A54145 (A,C,D) and acrylodan-labeled A54145 (B,C,D) to
increasing  concentrations  of  calcium.  Experimental  conditions  as  in  Figure  3.  A:  The  intrinsic
fluorescence of tryptophan-1 was excited at 280 nm. B: The fluorescence of acrylodan was excited at
360 nm. C: Acrylodan fluorescence (excited at 360 nm) of a mixture of acrylodan-A54145 (0.5  μM
final) and native A54145 (2.5 μM final) incubated with DMPC/DMPG vesicles and increasing calcium
concentrations. D: Mean wavelength of tryptophan emission and intensity of acrylodan emission at 475
nm as functions of calcium concentration. The initial rise in acrylodan emission reverses concomitantly
with the blue shift of the tryptophan emission. 
Figure 5: Fluorescence anisotropy of kynurenine-13 in  daptomycin (3  μM)  and of tryptophan-1 in
A54145 (3  μM) in the presence of DMPG/DMPC membranes (250 μM  total lipid)  as a function of
calcium concentration. Temperature: 37ºC. Error bars represent standard deviations from 3 independent
experiments.  
Figure 6: Summary of experimental findings from the current study, as well as from a recent study
using pyrene fluorescence  [15]. The schematic of the lipopeptide molecule combines features from
native daptomycin and A54145 as well as the labeled analogues. Circles represent fluorescent residues
or labels, whereas semicircles represent calcium-binding sites (the exact locations of which are not
certain).  Pyrene, which was incorporated into the N-terminally attached fatty acyl tail, is represented
by  a  polygon  in  dashed  outline.  The  fluorescence  signals  of  acrylodan  attached  to  residue  6
(daptomycin) and residue 8 (A54145) are activated upon binding of the first calcium ion. Binding of
the second calcium ion activates the fluorescence signals of tryptophan-1 and kynurenine-13, and at the
same  time  reduces  the  label  fluorescence  of  residues  6  and  8  through  oligomerization  and  self-
quenching. All four fluorophores respond in a manner that indicates increased membrane interaction
upon calcium binding. Excimer formation of pyrene is detectable after binding of the first calcium but
becomes more intense after binding of the second one. 
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